Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson, T Fouweather… - bmj, 2021 - bmj.com
Objective To assess the use of proton pump inhibitors (PPIs) to treat persistent throat
symptoms. Design Pragmatic, double blind, placebo controlled, randomised trial. Setting …
被引用次数：57 相关文章

Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial.

J O'Hara, DD Stocken, GC Watson… - … (Clinical Research ed …, 2021 - europepmc.org
Main outcome measures Primary outcome was symptomatic response at 16 weeks
measured using the total reflux symptom index (RSI) score. Secondary outcomes included …

Useof proton pump inhibitors to treat persistentthroat symptoms: multicentre, double blind, randomised, placebo controlledtrial

J O'Hara, DD Stocken, GC Watson… - BMJ: British Medical …, 2021 - search.proquest.com
Main outcome measures Primary outcome was symptomatic response at 16weeks
measured using the total reflux symptomindex (RSI) score. Secondary outcomes …
[HTML] nih.gov

[HTML][HTML] Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson, T Fouweather… - The BMJ, 2021 - ncbi.nlm.nih.gov
Main outcome measures Primary outcome was symptomatic response at 16 weeks
measured using the total reflux symptom index (RSI) score. Secondary outcomes included …

Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson, T Fouweather… - The …, 2021 - strathprints.strath.ac.uk
Objective To assess the use of proton pump inhibitors (PPIs) to treat persistent throat
symptoms. Design Pragmatic, double blind, placebo controlled, randomised trial. Setting …
[PDF] binasss.sa.cr

[PDF][PDF] Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson, T Fouweather… - bmj, 2021 - binasss.sa.cr
Use of proton pump inhibitors to treat persistent Page 1 the bmj | BMJ 2021;372:m4903 | doi:
10.1136/bmj.m4903 1 RESEARCH Use of proton pump inhibitors to treat persistent throat …
[PDF] brookes.ac.uk

[PDF][PDF] Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson, T Fouweather… - bmj, 2021 - radar.brookes.ac.uk
Use of proton pump inhibitors to treat persistent Page 1 the bmj | BMJ 2021;372:m4903 | doi:
10.1136/bmj.m4903 1 RESEARCH Use of proton pump inhibitors to treat persistent throat …

[引用][C] Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson… - British Medical …, 2021 - eprints.ncl.ac.uk
Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind,
randomised, placebo controlled trial - ePrints - Newcastle University Newcastle University …

Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson… - BMJ (Clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To assess the use of proton pump inhibitors (PPIs) to treat persistent throat
symptoms. Design Pragmatic, double blind, placebo controlled, randomised trial. Setting …
[HTML] bmj.com

[HTML][HTML] Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial

J O'Hara, DD Stocken, GC Watson, T Fouweather… - BMJ, 2021 - bmj.com
Objective To assess the use of proton pump inhibitors (PPIs) to treat persistent throat
symptoms. Design Pragmatic, double blind, placebo controlled, randomised trial. Setting …